IPO GMP Today: Anlon Healthcare IPO To Open For Subscription Tomorrow: Should You Bet? Check Latest Info

IPO GMP Today: Anlon Healthcare's initial public offering (IPO) is all set to open for subscription on Tuesday, August 25. The mainboard IPO will be listed on the BSE and NSE after the subscription period.

For investors who are planning to invest money in the Gujarat-based pharmaceutical company, here are full details about Anlon Healthcare IPO, including its grey market premium (GMP), listing price, lot size, etc.

Anlon Healthcare IPO GMP Today

Anlon Healthcare IPO GMP stood at Rs 0, according to Chittorgarh.com at 9:30 am on Monday. The company has fixed a price band of Rs 91 per share. The estimated listing price is Rs 91, which includes the addition of its cap price and GMP. Given its current IPO GMP, the IPO is expected to see no gain or loss per share.

Anlon Healthcare IPO: Lot Size

With this IPO, Anlon Healthcare aims to raise Rs 121.01 crore. The stock is entirely a fresh issue of 1.33 crore. Anlon Healthcare IPO lot size is fixed at Rs 164 shares. The IPO's total issue size is 1,33,00,000 shares, which is equivalent to Rs 121.03 crore.
According to Chittorgarh.com, retail investors can bid for a minimum of 164 shares and more, equivalent to Rs 14,924. Retail investors can bid for a maximum of 13 lots (2,132 shares), equivalent to Rs 1,94,012. SHNIs can bid for a minimum of 13 lots and a maximum of 67 lots.

Anlon Healthcare IPO: Price Band

The company has fixed a price band of Rs 86 to Rs 91 per share with a face value of Rs 10 per share. Anlon Healthcare IPO allocation is fixed as 75% (maximum) to Qualified institutional buyers (QIBs), 10% (maximum) to retail investors and 15% (max) to NIIs.

Anlon Healthcare IPO: Should You Subscribe?

Anlon Healthcare has built a strong presence as a chemical manufacturing company. It has a strong presence in the pharmaceutical intermediates and APIs, manufactured in compliance with pharmacopoeia standards such as IP, BP, EP, JP, and USP

"We recommend subscribing to the issue, as the planned capacity expansion from 400 MTPA to 1,100 MTPA at Rajkot, Gujarat, is set to nearly triple scale, with revenue expected to double over the next 2-3 years, offering a compelling long term growth opportunity in the Indian pharmaceutical sector," noted SMIFs Limited in its report.

About Anlon Healthcare IPO

The Gujarat-based chemical manufacturing company was established in 2013. Anlon Healthcare majorly deals with the manufacturing of Pharma intermediates and active pharmaceutical ingredients (APIs).

The company manufactures high-purity intermediates for API production and also many APIs which are used in medicines, personal care, etc. Apart from manufacturing pharmaceutical intermediaries, the company also offers custom manufacturing for complex chemicals, exceeding purity standards and reducing impurities for customers.

The views and recommendations expressed are solely those of the individual analysts or entities and do not reflect the views of Goodreturns.in or Greynium Information Technologies Private Limited (together referred as "we"). We do not guarantee, endorse or take responsibility for the accuracy, completeness or reliability of any content, nor do we provide any investment advice or solicit the purchase or sale of securities. All information is provided for informational and educational purposes only and should be independently verified from licensed financial advisors before making any investment decisions.